Milestones

DEVA (Doctors, Pharmacists and Instruments) was founded with 27 shareholders and a capital of 500,000 TL.

• The first manufacturing facility is established in Tünel, Beyoğlu.

• The Bomonti pharmaceutical plant was opened.

• The ampoule plant was set up.

• The production of Tetracycline and Oxytetracycline was realized as the first pharmaceutical raw material in Turkey.

• Vetaş Veteriner ve Tarım İlaçları A.Ş. is established to manufacture and market veterinary and agricultural products in 1973 under the umbrella of the company, Deva Holding. The first products placed on the market were Vetimisin Powder for Solution for Injection and Vitaform Powder for Oral Solution. Vetimisin remains the market leader since the first day it was placed on the market. The largest pharmaceutical manufacturing facility was purchased from Farmitalia.

• Vetaş Oksitosin, the first oxytocin for veterinary use, and Vetaş Atropin, the first anticholinergic product in the Turkish market, are launched.

• The Carlo Erba pharmaceutical plant was purchased.

• With the production of Gentamicine in its active pharmaceutical ingredient manufacturing facilities, it was listed among 5 establishments to produce this active ingredient throughout the world.

• Nervit Kompoze, the first B1, B6 vitamin for veterinary use in the Turkish market, is launched.
• The shares of DEVA Holding started to be traded on the Istanbul Stock Exchange.

• The first Gentamycin-containing products are launched in the market: Gentavet Solution for Injection, Gentavet-G Eye and Ear Drops, and Gentavet-D Skin Ointment.

• The majority ownership of DEVA Holding was transferred to EastPharma Limited, a business venture of GEM Global Equities Management S.A. In connection with this restructuring, Phillip Haas was elected as the new Chairman of the Board of Directors in July 2006.

• The R&D center "DEVARGE" was established.

• DEVA was deemed worthy of the first prize in the "R&D Study of the Year" category of the Golden Mortar competition.

• DEVA Holding facilities, receive GMP certification by the Turkish Ministry of Food, Agriculture and Animal Husbandry Vetakademi Kampüs was launched, with the slogan "Led by Science," offering educational meetings to respond to the scientific needs of veterinarians.

• As of 30.12.2016, the company merged with DEVA Holding A.Ş., its main shareholder. It will continue operating within DEVA Holding A.Ş. under the Vetaş brand. The Kartepe Manufacturing Plant received FDA approval.

• Turkey's largest pharmaceutical logistics center started its operations with a 32,000-pallet capacity.

• The first sustainability report has been published.

• US FDA and GMP renewal approvals were received at the Çerkezköy-I and Çerkezköy-II Manufacturing Facilities.
• GMP renewal approvals were received at the Kartepe Manufacturing Facilities.
• The Golden Mortar Award and the 11th Chemistry R&D Project Market Award were granted.

• Vetaş celebrated its 50th anniversary.

• The first product in the Pet category was launched.

• 12 new products were launched to the market.